Cogent Biosciences Inc (COGT) concluded trading on Thursady at a closing price of $8.95, with 14.14 million shares of worth about $126.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.03% during that period and on Thursady the price saw a gain of about 4.56%. Currently the company’s common shares owned by public are about 69.89M shares, out of which, 69.43M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 10.26, or with a gain of 4.56%. Stock saw a price change of 2.87% in past 5 days and over the past one month there was a price change of 93.30%. Year-to-date (YTD), COGT shares are showing a performance of 52.21% which decreased to -28.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.67 but also hit the highest price of $13.51 during that period. The average intraday trading volume for Cogent Biosciences Inc shares is 2.26 million. The stock is currently trading 48.11% above its 20-day simple moving average (SMA20), while that difference is up 60.08% for SMA50 and it goes to -5.35% lower than SMA200.
Cogent Biosciences Inc (NASDAQ: COGT) currently have 69.89M outstanding shares and institutions hold larger chunk of about 92.32% of that.
The stock has a current market capitalization of $770.77M and its 3Y-monthly beta is at 1.50. It has posted earnings per share of -$2.34 in the same period. It has Quick Ratio of 8.24 while making debt-to-equity ratio of 0.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for COGT, volatility over the week remained 13.50% while standing at 10.96% over the month.
Analysts are in expectations that Cogent Biosciences Inc (COGT) stock would likely to be making an EPS of -$0.55 in the current quarter, while forecast for next quarter EPS is -$0.53 and it is -$2.11 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.66 which is -$0.37 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.56 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 4.85% while it is estimated to increase by 7.69% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on February 08, 2024 offering a Buy rating for the stock and assigned a target price of $11 to it. Coverage by Wedbush stated Cogent Biosciences Inc (COGT) stock as a Neutral in their note to investors on December 11, 2023, suggesting a price target of $5 for the stock. On December 08, 2023, JP Morgan Initiated their recommendations, while on April 28, 2023, Robert W. Baird Initiated their ratings for the stock with a price target of $20. Stock get a Buy rating from H.C. Wainwright on March 27, 2023.
